Cell envelope stress response in cell wall-deficient L-forms of Bacillus subtilis

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 11, 2012, Pages 5907-5915

  Wolf, Diana ^a   Domínguez Cuevas, Patricia ^b   Daniel, Richard A ^b   Mascher, Thorsten ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; BETA GALACTOSIDASE; BETA LACTAM ANTIBIOTIC; DAPTOMYCIN; MERSACIDIN; NISIN; SPECTINOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BIOASSAY; BIOSENSOR; BIOSYNTHESIS; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTOPLAST; REPORTER GENE;

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BACITRACIN; BACTERIOCINS; CELL MEMBRANE; CELL WALL; DAPTOMYCIN; DRUG RESISTANCE, MICROBIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REPORTER; L FORMS; LAC OPERON; MEMBRANE LIPIDS; PEPTIDES; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; VANCOMYCIN;

EID: 84868013756     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00770-12     Document Type: Article

References (77)

1. Allan EJ. 1991. Induction and cultivation of a stable L form of Bacillus subtilis. J. Appl. Bacteriol. 70:339-343.
2. Bernard R, Guiseppi A, Chippaux M, Foglino M, Denizot F. 2007. Resistance to bacitracin in Bacillus subtilis: Unexpected requirement of the BceAB ABC transporter in the control of expression of its own structural genes. J. Bacteriol. 189:8636-8642.
3. Bierbaum G, Sahl HG. 2009. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10:2-18.
4. Bouhss A, Crouvoisier M, Blanot D, Mengin-Lecreulx D. 2004. Purification and characterization of the bacterial MraY translocase catalyzing the first membrane step of peptidoglycan biosynthesis. J. Biol. Chem. 279: 29974-29980.
5. Breukink E, de Kruijff B. 2006. Lipid II as a target for antibiotics. Nat. Rev. Drug Discov. 5:321-332.
6. Breukink E, et al. 1997. The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 36:6968 - 6976.
7. Breukink E, et al. 1999. Use of the cell wall precursor lipid II by a poreforming peptide antibiotic. Science 286:2361-2364.
8. Burkard M, Stein T. 2008. Microtiter plate bioassay to monitor the interference of antibiotics with the lipid II cycle essential for peptidoglycan biosynthesis. J. Microbiol. Methods 75:70-74.
9. Burmeister HR, Hesseltine CW. 1968. Induction and propagation of a Bacillus subtilis L form in natural and synthetic media. J. Bacteriol. 95: 1857-1861.
10. Cao M, et al. 2002. Defining the Bacillus subtilis σ regulon: a comparative analysis of promoter consensus search, runoff transcription/ macroarray analysis (ROMA), and transcriptional profiling approaches. J. Mol. Biol. 316:443-457.
11. M regulons. Mol. Microbiol. 45:1267-1276.
12. Cotroneo N, Harris R, Perlmutter N, Beveridge T, Silverman JA. 2008. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. Antimicrob. Agents Chemother. 52:2223-2225.
13. Courvalin P. 2006. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42(Suppl 1):S25-S34.
14. Daniel RA, Errington J. 1993. DNA sequence of the murE-murD region of Bacillus subtilis 168. J. Gen. Microbiol. 139:361-370.
15. Dell'Era S, et al. 2009. Listeria monocytogenes L forms respond to cell wall deficiency by modifying gene expression and the mode of division. Mol. Microbiol. 73:306-322.
16. Dienes L, Weinberger HJ. 1951. The L forms of bacteria. Bacteriol. Rev. 15:245-288.
17. Dintner S, et al. 2011. Co-evolution of ABC-transporters and two-component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes bacteria. J. Bacteriol. 193:3851-3862.
18. Domingue GJ, Sr, Woody HB. 1997. Bacterial persistence and expression of disease. Clin. Microbiol. Rev. 10:320-344.
19. Dominguez-Cuevas P, Mercier R, Leaver M, Kawai Y, Errington J. 2012. The rod to L form transition of Bacillus subtilis is limited by a requirement for the protoplast to escape from the cell wall sacculus. Mol. Microbiol. 83:52-66.
20. Foster SJ, Popham DL. 2002. Structure and synthesis of cell wall, spore cortex, teichoic acid, S-layers and capsules, p 21-41. In Sonenshein AL, Hoch JA, Losick R (ed), Bacillus subtilis and its closest relatives: from genes to cells. ASM Press, Washington, DC.
21. Fuller E, et al. 2005. Beta-lactam resistance in Staphylococcus aureus cells that do not require a cell wall for integrity. Antimicrob. Agents Chemother. 49:5075-5080.
22. Garcera MJ, Elferink MG, Driessen AJ, Konings WN. 1993. In vitro pore-forming activity of the lantibiotic nisin. Role of protonmotive force and lipid composition. Eur. J. Biochem. 212:417-422.
23. Gebhard S, Mascher T. 2011. Antimicrobial peptide sensing and detoxification modules: unraveling the regulatory circuitry of Staphylococcus aureus. Mol. Microbiol. 81:581-587.
24. Gilpin RW, Young FE, Chatterjee AN. 1973. Characterization of a stable L form of Bacillus subtilis 168. J. Bacteriol. 113:486-499.
25. Hachmann A-B, Angert ER, Helmann JD. 2009. Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin. Antimi-crob. Agents Chemother. 53:1598-1609.
26. Hachmann A-B, et al. 2011. Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in Bacillus subtilis. Antimicrob. Agents Chemother. 55:4326-4337.
27. Harwood CR, Cutting SM. 1990. Molecular biological methods for Bacillus. John Wiley & Sons, Chichester, United Kingdom.
28. Hiron A, Falord M, Valle J, Debarbouille M, Msadek T. 2011. Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol. Microbiol. 81:602-622.
29. Jordan S, Hutchings MI, Mascher T. 2008. Cell envelope stress response in Gram-positive bacteria. FEMS Microbiol. Rev. 32:107-146.
30. Jordan S, Junker A, Helmann JD, Mascher T. 2006. Regulation of LiaRS-dependent gene expression in Bacillus subtilis: Identification of inhibitor proteins, regulator binding sites and target genes of a conserved cell envelope stress-sensing two-component system. J. Bacteriol. 188: 5153-5166.
31. King JR. 1986. L forms of group D Streptococcus, p 43-58. In Madoff S (ed), The bacterial L forms. Marcel Dekker Inc., New York, NY.
32. Kuroda M, et al. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821.
33. Landman OE, Halle S. 1963. Enzymically and physically induced inheritance changes in Bacillus subtilis. J. Mol. Biol. 7:721-738.
34. Leaver M, Dominguez-Cuevas P, Coxhead JM, Daniel RA, Errington J. 2009. Life without a wall or division machine in Bacillus subtilis. Nature 457:849-853.
35. Linnett PE, Strominger JL. 1973. Additional antibiotic inhibitors of pep-tidoglycan synthesis. Antimicrob. Agents Chemother. 4:231-236.
36. Maisnier-Patin S, Richard J. 1996. Cell wall changes in nisin-resistant variants of Listeria innocua grown in the presence of high nisin concentrations. FEMS Microbiol. Lett. 140:29-35.
37. Markova N, Slavchev G, Michailova L, Jourdanova M. 2010. Survival of Escherichia coli under lethal heat stress by L form conversion. Int. J. Biol. Sci. 6:303-315.
38. Martinez B, Zomer AL, Rodriguez A, Kok J, Kuipers OP. 2007. Cell envelope stress induced by the bacteriocin Lcn972 is sensed by the lacto-coccal two-component system CesSR. Mol. Microbiol. 64:473-486.
39. Mascher T, Margulis NG, Wang T, Ye RW, Helmann JD. 2003. Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitra-cin stimulon. Mol. Microbiol. 50:1591-1604.
40. Mascher T, Zimmer SL, Smith TA, Helmann JD. 2004. Antibioticinducible promoter regulated by the cell envelope stress-sensing two-component system LiaRS of Bacillus subtilis. Antimicrob. Agents Che-mother. 48:2888-2896.
41. McCallum N, Meier PS, Heusser R, Berger-Bachi B. 2011. Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus. Antimicrob. Agents Chemother. 55:1391-1402.
42. Mercier R, Dominguez-Cuevas P, Errington J. 2012. Crucial role for membrane fluidity in proliferation ofprimitive cells. Cell Rep. 1:417-423.
43. Michailova L, Kussovsky V, Radoucheva T, Jordanova M, Markova N. 2007. Persistence of Staphylococcus aureus L form during experimental lung infection in rats. FEMS Microbiol. Lett. 268:88-97.
44. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
45. Ming L-J, Epperson JD. 2002. Metal binding and structure-activity relationship of the metalloantibiotic peptide bacitracin. J. Inorg. Biochem. 91:46-58.
46. Ming L-J. 2003. Structure and function of "metalloantibiotics." Med. Res. Rev. 23:697-762.
47. Müller A, Ulm H, Reder-Christ K, Sahl HG, Schneider T. 2012. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors. Microb. Drug Resist. 18:261-270.
48. Muraih JK, Pearson A, Silverman J, Palmer M. 2011. Oligomerization of daptomycin on membranes. Biochim. Biophys. Acta 1808:1154-1160.
49. Ohki R, Giyanto et al. 2003. The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis. Mol. Microbiol. 49:1135-1144.
50. O'Leary JO, et al. 2004. Effects of sarA inactivation on the intrinsic multidrug resistance mechanism of Staphylococcus aureus. FEMS Microbiol. Lett. 237:297-302.
51. + on the intracellular pH ofan Escherichia coli L form. J. Gen. Microbiol. 138:1265-1270.
52. Pietiäinen M, et al. 2009. Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles ofvraDE and vraSR in antimicrobial resistance. BMC Genomics 10:429.
53. Pietiäinen M, et al. 2005. Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems. Microbiology 151:1577-1592.
54. Pogliano J, Pogliano N, Silverman JA. 2012. Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J. Bacteriol. 194:4494-4504.
55. Rietkötter E, Hoyer D, Mascher T. 2008. Bacitracin sensing in Bacillus subtilis. Mol. Microbiol. 68:768-785.
56. Salzberg LI, Luo Y, Hachmann A-B, Mascher T, Helmann JD. 2011. The Bacillus subtilis GntR family repressor YtrA responds to cell wall antibiotics. J. Bacteriol. 193:5793-5801.
57. Schneider T, et al. 2009. The lipopeptide antibiotic friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob. Agents Chemother. 53:1610-1618.
58. Schneider T, et al. 2010. Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science 328:1168-1172.
59. Schrecke K, Staron A, Mascher T. 2012. Two-component signaling in the Gram-positive envelope stress response: intramembrane-sensing histidine kinases and accessory membrane proteins, p 199-229. In Gross R, Beier D (ed), Two component systems in bacteria. Horizon Scientific Press, Hethersett, United Kingdom.
60. Sharp JT. 1954. L colonies from hemolytic streptococci: new technic in the study of L forms of bacteria. Proc. Soc. Exp. Biol. Med. 87:94-97.
61. Shimotsu H, Henner DJ. 1986. Modulation of Bacillus subtilis levansu-crasegene expression by sucrose and regulation of the steady-state mRNA level by sacU and sacQ genes. J. Bacteriol. 168:380-388.
62. Silverman JA, Perlmutter NG, Shapiro HM. 2003. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47:2538-2544.
63. Smyth EG, Pallett AP. 1988. Vancomycin. Br. J. Hosp. Med. 39:308-312.
64. Staron A, Finkeisen DE, Mascher T. 2011. Peptide antibiotic sensing and detoxification modules of Bacillus subtilis. Antimicrob. Agents Chemother. 55:515-525.
65. Staron A, et al. 2009. The third pillar of bacterial signal transduction: classification of the extracytoplasmic function (ECF) σ factor protein family. Mol. Microbiol. 74:557-581.
66. Stone KJ, Strominger JL. 1971. Mechanism of action of bacitracin: com-plexation with metal ion and C 55-isoprenyl pyrophosphate. Proc. Natl. Acad. Sci. U. S. A. 68:3223-3227.
67. Storm DR, Strominger JL. 1973. Complex formation between bacitracin peptides and isoprenyl pyrophosphates. The specificity of lipid-peptide interactions. J. Biol. Chem. 248:3940-3945.
68. Straus SK, Hancock RE. 2006. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimi-crobial peptides and lipopeptides. Biochim. Biophys. Acta 1758:1215-1223.
69. Stülke J, et al. 1997. Induction of the Bacillus subtilis ptsGHI operon by glucose is controlled by a novel antiterminator, GlcT. Mol. Microbiol. 25:65-78.
70. Wang D, Chen Z, Hu Z, Yuan W, Rao X. 2011. A recombinant antimicrobial peptide inhibits the growth of oxacillin-induced L forms of Staphylococcus aureus. Int. J. Antimicrob. Agents 38:177-178.
71. Wang KX, Chen L. 2004. Helicobacter pylori L form and patients with chronic gastritis. World J. Gastroenterol. 10:1306-1309.
72. Ward JB. 1975. Peptidoglycan synthesis in L-phase variants of Bacillus licheniformis and Bacillus subtilis. J. Bacteriol. 124:668-678.
73. Wecke T, et al. 2009. Daptomycin versus friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses. Antimicrob. Agents Che-mother. 53:1619-1623.
74. Wolf D, et al. 2010. In-depth profiling of the LiaR response of Bacillus subtilis. J. Bacteriol. 192:4680-4693.
75. Wyrick PB, McConnell M, Rogers HJ. 1973. Genetic transfer of the stable L form state to intact bacterial cells. Nature 244:505-507.
76. Wyrick PB, Rogers HJ. 1973. Isolation and characterization of cell wall-defective variants of Bacillus subtilis and Bacillus licheniformis. J. Bacteriol. 116:456-465.
77. Xiong YQ, Mukhopadhyay K, Yeaman MR, Adler-Moore J, Bayer AS. 2005. Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus. Anti-microb. Agents Chemother. 49:3114-3121.